Market Momentum Report: NeuroPace Inc (NPCE)’s Negative Close at 11.81

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

The price of NeuroPace Inc (NASDAQ: NPCE) closed at $11.81 in the last session, down -8.80% from day before closing price of $12.95. In other words, the price has decreased by -$8.80 from its previous closing price. On the day, 0.55 million shares were traded.

Ratios:

We take a closer look at NPCE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.77 and its Current Ratio is at 5.59. In the meantime, Its Debt-to-Equity ratio is 7.48 whereas as Long-Term Debt/Eq ratio is at 7.30.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on January 21, 2025, initiated with a Buy rating and assigned the stock a target price of $17.

On March 14, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $16 to $20.

On January 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $22.Leerink Partners initiated its Outperform rating on January 30, 2024, with a $22 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 21 ’25 when Morrell Martha sold 78,334 shares for $13.72 per share. The transaction valued at 1,074,844 led to the insider holds 81,993 shares of the business.

KCK LTD. sold 5,270,845 shares of NPCE for $49,545,943 on Feb 20 ’25. The 10% Owner now owns 0 shares after completing the transaction at $9.40 per share. On Jan 30 ’25, another insider, Morrell Martha, who serves as the CHIEF MEDICAL OFFICER of the company, sold 200 shares for $15.00 each. As a result, the insider received 3,000 and left with 86,762 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 4.80 while its Price-to-Book (P/B) ratio in mrq is 35.80.

Stock Price History:

Over the past 52 weeks, NPCE has reached a high of $17.10, while it has fallen to a 52-week low of $5.45. The 50-Day Moving Average of the stock is -6.64%, while the 200-Day Moving Average is calculated to be 33.25%.

Shares Statistics:

A total of 29.78M shares are outstanding, with a floating share count of 21.64M. Insiders hold about 30.35% of the company’s shares, while institutions hold 39.22% stake in the company.

Most Popular